BioAtla IncBCAB
Price$1.30

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $2MTTM through 31 Dec 2025
Net Income -$59.6MTTM through 31 Dec 2025
Free Cash Flow -$48.2MTTM through 31 Dec 2025

Margins

Current
Operating Margin-2,965.0%
Net Margin-2,980.0%

Returns

N/A (negative equity)ROE

Balance Sheet Health

Debt / EquityN/A (negative equity)
Current Ratio0.37x
Net Debt-$7.1Mnet cash position
Cash & Equivalents$7.1M

Quality Metrics

FCF Margin-2,410.0%
Earnings-Beat Rate75.0%

Dividend

No dividend
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.